Why Patients Switch From Mounjaro To Wegovy Privately
Can You Change From Mounjaro To Wegovy Through Private Prescription?
The decision to change from Mounjaro to Wegovy through private prescription services offers significant advantages over the NHS route. Unlike the NHS pathway requiring GP referral to specialist weight management services with typical waiting times exceeding six months, private prescription allows immediate access to clinical assessment. EverydayMeds provides this service through our GPhC-registered pharmacy (#9012878), ensuring the same medication quality as NHS provision but without bureaucratic delays.
When you change from Mounjaro to Wegovy privately, you maintain continuity of care whilst accessing different therapeutic mechanisms. Mounjaro (tirzepatide) works as a dual GIP and GLP-1 receptor agonist, whilst Wegovy (semaglutide) targets GLP-1 receptors specifically. This difference may be clinically relevant for some patients, and our registered prescribers can assess whether switching aligns with your treatment goals during the online consultation process.
Private Prescription Pricing When You Change From Mounjaro To Wegovy
Understanding the cost implications when you change from Mounjaro to Wegovy helps inform treatment decisions. Our transparent pricing structure starts with the 0.25mg starter dose at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the 2.4mg maintenance dose (£209.99). New customers benefit from discount code FIRST40, whilst returning customers use DOSE25, both applied at checkout to reach these final prices.
Bundle options provide supply convenience when you change from Mounjaro to Wegovy, such as our Intro Duo (0.25mg & 0.5mg) at £169.99 or the Progress Trio (0.5mg, 1mg & 1.7mg) at £369.99. These bundles ensure uninterrupted treatment progression without multiple ordering requirements. The Ultimate Stability Trio provides three months of maintenance 2.4mg supply at £649.99, ideal for established patients transitioning from Mounjaro who wish to secure consistent Wegovy provision.
Clinical Evidence Supporting The Change From Mounjaro To Wegovy
The decision to change from Mounjaro to Wegovy should be informed by robust clinical evidence from the STEP trial programme. In STEP 1, patients taking Wegovy alongside diet and exercise experienced approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). STEP 5 demonstrated sustained 15.2% weight reduction at two years, whilst the SELECT cardiovascular outcomes trial showed 20% reduction in major cardiovascular events.
These clinical outcomes may support the rationale to change from Mounjaro to Wegovy in certain patient populations. However, both medications represent prescription-only medicines requiring individualised clinical assessment. Direct head-to-head comparisons between Mounjaro and Wegovy trials are not appropriate due to different study designs, patient populations, and endpoints, emphasising why professional prescriber guidance remains essential when considering treatment switches.
How Wegovy Works When You Change From Mounjaro
Understanding the mechanism when you change from Mounjaro to Wegovy reveals important therapeutic differences. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural incretin hormones regulating appetite and glucose metabolism. The medication acts on brain appetite centres to reduce hunger signals whilst promoting satiety after smaller meal portions. This mechanism differs from Mounjaro's dual GIP and GLP-1 approach, potentially offering different therapeutic benefits. Weekly Wegovy injections using the FlexTouch pen system provide consistent medication levels, supporting sustained appetite regulation alongside a reduced-calorie diet and increased physical activity.
Ordering Process To Change From Mounjaro To Wegovy
The streamlined process to change from Mounjaro to Wegovy begins with our three-minute online clinical assessment covering medical history, current medications, and treatment objectives. This assessment undergoes review by registered prescribers within standard three working days, or within 24 hours using our express service. Once approved, your prescription-only medicine ships via next-day delivery using temperature-controlled cold-chain logistics to ensure medication integrity. The entire process bypasses traditional NHS referral requirements whilst maintaining clinical safety standards. Payment includes final pricing with applicable discount codes, ensuring transparency without hidden charges throughout your treatment transition.
Storage Considerations When You Change From Mounjaro To Wegovy
Practical storage requirements when you change from Mounjaro to Wegovy offer improved convenience compared to tirzepatide. Wegovy requires refrigeration at 2-8°C before first use but tolerates room temperature storage below 30°C for up to six weeks once removed from refrigeration. This represents a significant advantage over Mounjaro's 21-day room temperature limit, particularly beneficial for travel or lifestyle flexibility. The FlexTouch pen delivery system provides consistent dosing accuracy throughout the mandatory escalation schedule: 0.25mg for weeks 1-4, 0.5mg for weeks 5-8, 1mg for weeks 9-12, 1.7mg for weeks 13-16, and 2.4mg maintenance from week 17 onwards.
Private Prescription Advantages When You Change From Mounjaro To Wegovy
The private prescription route to change from Mounjaro to Wegovy eliminates common NHS obstacles including lengthy specialist waiting lists and restrictive eligibility criteria. NHS weight management services often require demonstration of failed conventional treatments and attendance at multiple appointments before considering prescription options. Private prescription removes these barriers whilst providing identical medication quality from MHRA-approved sources.
Additionally, when you change from Mounjaro to Wegovy privately, treatment decisions remain between you and your prescriber without external funding restrictions or formulary limitations. This autonomy proves particularly valuable for patients experiencing specific side effects with tirzepatide or those seeking different therapeutic approaches. EverydayMeds maintains the same clinical standards as NHS provision whilst offering superior accessibility and patient choice in treatment pathways.
Complete Your Change From Mounjaro To Wegovy Today
Beginning your change from Mounjaro to Wegovy requires simple steps starting with our online clinical assessment at https://everydaymeds.co.uk/collections/wegovy. New customers apply discount code FIRST40 at checkout, whilst returning customers use DOSE25 to access our competitive pricing structure. Our registered prescribers provide expert guidance on timing your medication switch and managing any transition considerations specific to your clinical situation. Remember that Wegovy represents a prescription-only medicine requiring ongoing clinical oversight alongside lifestyle modifications. Treatment success depends on combining semaglutide therapy with reduced-calorie nutrition and increased physical activity for optimal outcomes.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
